Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study

Authors: Pengcheng Huai, Furong Li, Zhen Li, Lele Sun, Xi’an Fu, Qing Pan, Gongqi Yu, Zemin Chai, Tongsheng Chu, Zihao Mi, Fangfang Bao, Honglei Wang, Bingni Zhou, Chuan Wang, Yonghu Sun, Guiye Niu, Yuan Zhang, Fanghui Fu, Xiaoqiao Lang, Xiaoling Wang, Hui Zhao, Daina Liu, Hong Liu, Dianchang Liu, Jian Liu, Aiqiang Xu, Furen Zhang

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

A population-based study of Chlamydia trachomatis (CT) infections is essential in designing a specific control program; however, no large investigation of CT infections among the general population in mainland China has been conducted since 2000. We aimed to determine the prevalence, risk factors, and associated medical costs of CT among residents, 18–49 years of age, in Shandong, China.

Methods

From May to August 2016, a multistage probability sampling survey involving 8074 individuals was distributed. Data were collected via face-to-face interviews, followed by self-administered questionnaire surveys. First-void urines were collected and tested for CT and Neisseria gonorrhoeae (NG) using nucleic acid amplification.

Results

The weighted prevalence of CT infection was 2.3% (95% confidence interval [CI], 1.5–3.2) in females and 2.7% (1.6–3.8) in males. Women, 30–34 years of age, had the highest prevalence of CT infections (3.5%, 2.6–4.4), while the highest prevalence of CT infections in males was in those 18–24 years of age (4.3%, 0.0–8.8). Neisseria gonorrhoeae infection had a prevalence of 0.1% (0.0–0.3) in women and 0.03% (0.0–0.1) in men. Risk factors for CT infections among females included being unmarried, divorced, or widowed (odds ratio [OR], 95% CI 3.57, 1.54–8.24) and having two or more lifetime sex partners (3.72, 1.14–12.16). Among males, first intercourse before 20 years of age (1.83, 1.10–3.02) and having two or more lifetime sex partners (1.85, 1.14–3.02) were associated with CT infections. The estimated lifetime cost of CT infections in patients 18–49 years of age in Shandong was 273 million (range, 172–374 million) China Renminbi in 2016.

Conclusions

This study demonstrated a high burden of CT infections among females < 35 years of age and males < 25 years of age in Shandong. Thus, a CT infection control program should focus on this population, as well as others with identified risk factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Unemo M, Bradshaw CS, Hocking JS, De Vries H, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17:e235–79.CrossRef Unemo M, Bradshaw CS, Hocking JS, De Vries H, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17:e235–79.CrossRef
3.
go back to reference Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17:716–25.CrossRef Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17:716–25.CrossRef
4.
go back to reference Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of sexual attitudes and lifestyles (Natsal). Lancet. 2013;382:1795–806.CrossRef Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of sexual attitudes and lifestyles (Natsal). Lancet. 2013;382:1795–806.CrossRef
5.
go back to reference Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;91:2229–36.CrossRef Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;91:2229–36.CrossRef
6.
go back to reference Parish WL, Laumann EO, Cohen MS, Pan S, Zheng H, Hoffman I, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA. 2003;289:1265–73.CrossRef Parish WL, Laumann EO, Cohen MS, Pan S, Zheng H, Hoffman I, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA. 2003;289:1265–73.CrossRef
7.
go back to reference Franceschi S, Smith JS, van den Brule A, Herrero R, Arslan A, Anh PT, et al. Cervical infection with chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis. 2007;34:563–9.PubMed Franceschi S, Smith JS, van den Brule A, Herrero R, Arslan A, Anh PT, et al. Cervical infection with chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis. 2007;34:563–9.PubMed
8.
go back to reference Zeng Y, Hesketh T. The effects of China's universal two-child policy. Lancet. 2016;388:1930–8.CrossRef Zeng Y, Hesketh T. The effects of China's universal two-child policy. Lancet. 2016;388:1930–8.CrossRef
9.
go back to reference Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201:S134–55.CrossRef Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201:S134–55.CrossRef
10.
go back to reference Peterman TA, Newman DR, Maddox L, Schmitt K, Shiver S. Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000-2011. Int J STD AIDS. 2015;26:113–9.CrossRef Peterman TA, Newman DR, Maddox L, Schmitt K, Shiver S. Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000-2011. Int J STD AIDS. 2015;26:113–9.CrossRef
11.
go back to reference Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137.CrossRef Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137.CrossRef
12.
go back to reference Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J. Prevalence of chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect. 2010;86:263–70.CrossRef Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J. Prevalence of chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect. 2010;86:263–70.CrossRef
13.
go back to reference Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M. A chlamydia prevalence survey of young women living in Melbourne. Victoria Sex Health. 2006;3:235–40.CrossRef Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M. A chlamydia prevalence survey of young women living in Melbourne. Victoria Sex Health. 2006;3:235–40.CrossRef
15.
go back to reference LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004;80:335–41.CrossRef LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004;80:335–41.CrossRef
16.
go back to reference Parra-Sanchez M, Palomares JC, Bernal S, Gonzalez MT, Sivianes N, Perez L, et al. Evaluation of the cobas 4800 CT/NG test for detecting chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diagn Microbiol Infect Dis. 2012;74:338–42.CrossRef Parra-Sanchez M, Palomares JC, Bernal S, Gonzalez MT, Sivianes N, Perez L, et al. Evaluation of the cobas 4800 CT/NG test for detecting chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diagn Microbiol Infect Dis. 2012;74:338–42.CrossRef
17.
go back to reference Chen S, Li J, van den Hoek A. Universal screening or prophylactic treatment for chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective? Sex Transm Dis. 2007;34:230–6.CrossRef Chen S, Li J, van den Hoek A. Universal screening or prophylactic treatment for chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective? Sex Transm Dis. 2007;34:230–6.CrossRef
18.
go back to reference Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol. 2002;186:929–37.CrossRef Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol. 2002;186:929–37.CrossRef
19.
go back to reference Wang QQ, Liu QZ, Xu JH. Guideline for sexually transmitted infection treatment and control in China. Shanghai: Shanghai Science and Technology Press; 2014. p. 108–9. Wang QQ, Liu QZ, Xu JH. Guideline for sexually transmitted infection treatment and control in China. Shanghai: Shanghai Science and Technology Press; 2014. p. 108–9.
20.
go back to reference Tuite AR, Jayaraman GC, Allen VG, Fisman DN. Estimation of the burden of disease and costs of genital chlamydia trachomatis infection in Canada. Sex Transm Dis. 2012;39:260–7.CrossRef Tuite AR, Jayaraman GC, Allen VG, Fisman DN. Estimation of the burden of disease and costs of genital chlamydia trachomatis infection in Canada. Sex Transm Dis. 2012;39:260–7.CrossRef
21.
go back to reference Xiao Z, Mehrotra P, Zimmerman R. Sexual revolution in China: implications for Chinese women and society. AIDS Care. 2011;23:105–12.CrossRef Xiao Z, Mehrotra P, Zimmerman R. Sexual revolution in China: implications for Chinese women and society. AIDS Care. 2011;23:105–12.CrossRef
22.
go back to reference Zhang L, Gao X, Dong Z, Tan Y, Wu Z. Premarital sexual activities among students in a university in Beijing. China Sex Transm Dis. 2002;29:212–5.CrossRef Zhang L, Gao X, Dong Z, Tan Y, Wu Z. Premarital sexual activities among students in a university in Beijing. China Sex Transm Dis. 2002;29:212–5.CrossRef
23.
go back to reference Yu XM, Guo SJ, Sun YY. Sexual behaviours and associated risks in Chinese young people: a meta-analysis. Sex Health. 2013;10:424–33.CrossRef Yu XM, Guo SJ, Sun YY. Sexual behaviours and associated risks in Chinese young people: a meta-analysis. Sex Health. 2013;10:424–33.CrossRef
24.
go back to reference Wong WC, Zhao Y, Wong NS, Parish WL, Miu HY, Yang LG, et al. Prevalence and risk factors of chlamydia infection in Hong Kong: a population-based geospatial household survey and testing. PLoS One. 2017;12:e172561. Wong WC, Zhao Y, Wong NS, Parish WL, Miu HY, Yang LG, et al. Prevalence and risk factors of chlamydia infection in Hong Kong: a population-based geospatial household survey and testing. PLoS One. 2017;12:e172561.
25.
go back to reference Torrone E, Papp J, Weinstock H. Prevalence of chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014;63:834–8.PubMedPubMedCentral Torrone E, Papp J, Weinstock H. Prevalence of chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014;63:834–8.PubMedPubMedCentral
26.
go back to reference Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mardh PA, et al. Cost effectiveness of screening for chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002;78:406–12.CrossRef Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mardh PA, et al. Cost effectiveness of screening for chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002;78:406–12.CrossRef
27.
go back to reference The US. Preventive services task force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med. 2001;20:90–4. The US. Preventive services task force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med. 2001;20:90–4.
28.
go back to reference Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis. 2012;39:92–6.CrossRef Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis. 2012;39:92–6.CrossRef
29.
go back to reference Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;34:1362–6.CrossRef Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;34:1362–6.CrossRef
30.
go back to reference Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;c1642:340. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;c1642:340.
32.
go back to reference Tao G, Hoover KW, Leichliter JS, Peterman TA, Kent CK. Self-reported chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis. 2012;39:605–7.CrossRef Tao G, Hoover KW, Leichliter JS, Peterman TA, Kent CK. Self-reported chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis. 2012;39:605–7.CrossRef
33.
go back to reference Shui M, Hu PC. Influence factors of sex desire for women in China [article in Chinese]. Chin J Fam Plan Obstet Gyneco. 2016;2:14–6,27. Shui M, Hu PC. Influence factors of sex desire for women in China [article in Chinese]. Chin J Fam Plan Obstet Gyneco. 2016;2:14–6,27.
34.
go back to reference Kaestle CE, Halpern CT, Miller WC, Ford CA. Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol. 2005;161:774–80.CrossRef Kaestle CE, Halpern CT, Miller WC, Ford CA. Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol. 2005;161:774–80.CrossRef
35.
go back to reference Ma Q, Ono-Kihara M, Cong L, Xu G, Pan X, Zamani S, et al. Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health. 2009;9:111.CrossRef Ma Q, Ono-Kihara M, Cong L, Xu G, Pan X, Zamani S, et al. Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health. 2009;9:111.CrossRef
37.
go back to reference Wang W, Wei C, Buchholz ME, Martin MC, Smith BD, Huang ZJ, et al. Prevalence and risks for sexually transmitted infections among a national sample of migrants versus non-migrants in China. Int J STD AIDS. 2010;21:410–5.CrossRef Wang W, Wei C, Buchholz ME, Martin MC, Smith BD, Huang ZJ, et al. Prevalence and risks for sexually transmitted infections among a national sample of migrants versus non-migrants in China. Int J STD AIDS. 2010;21:410–5.CrossRef
Metadata
Title
Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study
Authors
Pengcheng Huai
Furong Li
Zhen Li
Lele Sun
Xi’an Fu
Qing Pan
Gongqi Yu
Zemin Chai
Tongsheng Chu
Zihao Mi
Fangfang Bao
Honglei Wang
Bingni Zhou
Chuan Wang
Yonghu Sun
Guiye Niu
Yuan Zhang
Fanghui Fu
Xiaoqiao Lang
Xiaoling Wang
Hui Zhao
Daina Liu
Hong Liu
Dianchang Liu
Jian Liu
Aiqiang Xu
Furen Zhang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3432-y

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.